Hand function and quality of life in patients with diabetes mellitus before and during the COVID-19 pandemic

1 Douglas M, Katikireddi SV, Taulbut M, McKee M, McCartney G. Mitigating the wider health effects of

covid-19 pandemic response. BMJ. 2020;369:m1557. doi:10.1136/bmj.m1557.

2 Joseph SJ, Shoib S, Sg T, Bhandari SS. Psychological concerns and musculoskeletal pain amidst the COVID-19 lockdown. Open J Psychiatry Allied Sci. 2020;11(2):137–139. doi:10.5958/2394-2061.2020.00026.9.

3 Kasturi S, Price LL, Paushkin V, Salmon JE, McAlindon TE, Mandl LA. Impact of the first wave of the

COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective

cohort. Lupus. 2021;30(11):1747–1755. doi:10.1177/09612033211033981.

4 Cohen A, Selles RW, De Ridder WA, et al. What Is the Impact of the COVID-19 Pandemic on Quality

of Life and Other Patient-reported Outcomes? An Analysis of the Hand-Wrist Study Cohort. Clin Orthop

Relat Res. 2021;479(2):335–345. doi:10.1097/CORR.0000000000001514.

5 Bargon CA, Batenburg MCT, van Stam LE, et al. Impact of the COVID-19 pandemic on patient-reported

outcomes of breast cancer patients and survivors. JNCI Cancer Spectr. 2020;5(1):pkaa104. doi:10.1093/

jncics/pkaa104.

6 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease

Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648.

7 Al-Matubsi HY, Hamdan F, Alhanbali OA, Oriquat GA, Salim M. Diabetic hand syndromes as a clinical and

diagnostic tool for diabetes mellitus patients. Diabetes Res Clin Pract. 2011;94(2):225–229. doi:10.1016/j.

diabres.2011.07.012.

8 Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y. Dupuytren’s disease, carpal tunnel

syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995;20(1):109–114. doi:10.1016/S03635023(05)80068-1.

9 Kurimoto S, Suzuki M, Yamamoto M, Okui N, Imaeda T, Hirata H. Development and validation of a

ten-item questionnaire with explanatory illustrations to assess upper extremity disorders: favorable effect

of illustrations in the item reduction process. J Orthop Sci. 2011;16(6):737–744. doi:10.1007/s00776-0110148-x.

10 EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy.

1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9.

11 Abate M, Schiavone C, Salini V, Andia I. Management of limited joint mobility in diabetic patients. Diabetes

Metab Syndr Obes. 2013;6:197–207. doi:10.2147/DMSO.S33943.

12 Gamstedt A, Holm-Glad J, Ohlson CG, Sundström M. Hand abnormalities are strongly associated with the

duration of diabetes mellitus. J Intern Med. 1993;234(2):189–193. doi:10.1111/j.1365-2796.1993.tb00729.x.

13 Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren’s disease. J Bone Joint

Surg Br. 1984;66(3):322–325. doi:10.1302/0301-620X.66B3.6725338.

14 Shivde AJ, Dreizin I, Fisher MA. The carpal tunnel syndrome. A clinical - electrodiagnostic analysis.

Electromyogr Clin Neurophysiol. 1981;21(2–3):143–153.

15 Kuczmarski AS, Harris AP, Gil JA, Weiss AC. Management of diabetic trigger finger. J Hand Surg Am.

2019;44(2):150–153. doi:10.1016/j.jhsa.2018.03.045.

16 Tanaka K, Kawai T, Saisho Y, et al. Relationship between stage of diabetic retinopathy and pulse wave velocity in Japanese patients with type 2 diabetes. J Diabetes Res. 2013;2013:193514. doi:10.1155/2013/193514.

17 Haneda M, Noda M, Origasa H, et al. Japanese clinical practice guideline for diabetes 2016. Diabetol Int.

Nagoya J. Med. Sci. 85. 659–667, 2023

666

doi:10.18999/nagjms.85.4.659

Patients with DM during COVID-19

2018;9(1):1–45. doi:10.1007/s13340-018-0345-3.

Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. Effects of angiotensin converting enzyme inhibitors

and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic

review. BMJ. 2004;329(7470):828. doi:10.1136/bmj.38237.585000.7C.

19 Suzuki M, Kurimoto S, Shinohara T, Tatebe M, Imaeda T, Hirata H. Development and validation of an

illustrated questionnaire to evaluate disabilities of the upper limb. J Bone Joint Surg Br. 2010;92(7):963–969.

doi:10.1302/0301-620X.92B7.23410.

20 Kurimoto S, Yamamoto M, Shinohara T, Tatebe M, Iwatsuki K, Hirata H. Favorable effects of explanatory

illustrations attached to a self-administered questionnaire for upper extremity disorders. Qual Life Res.

2013;22(5):1145–1149. doi:10.1007/s11136-012-0233-4.

21 Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan.

Health Econ. 2002;11(4):341–353. doi:10.1002/hec.673.

22 Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151.

23 Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular senescence in type 2

diabetes: a therapeutic opportunity. Diabetes. 2015;64(7):2289–2298. doi:10.2337/db14-1820.

24 Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG. Biochemical evaluation of serum and flexor

tenosynovium in carpal tunnel syndrome. Microsurgery. 2002;22(8):378–385. doi:10.1002/micr.10065.

25 Tucci M, Barbieri R, Freeland A. Biochemical and histological analysis of the flexor tenosynovium in

patients with carpal tunnel syndrome. Biomed Sci Instrum. 1997;33:246–251.

26 Sharma D, Jaggi AS, Bali A. Clinical evidence and mechanisms of growth factors in idiopathic and diabetesinduced carpal tunnel syndrome. Eur J Pharmacol. 2018;837:156–163. doi:10.1016/j.ejphar.2018.08.017.

References End

18 Nagoya J. Med. Sci. 85. 659–667, 2023

667

doi:10.18999/nagjms.85.4.659

...